Fluid shear stress as a co-stimulatory cue to enhance T cell priming and restore activation in cancer patient T cells
The Journal of Immunology · 04.08.2026 · 215 (8)
DOI: 10.1093/jimmun/vkag166 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 06.08.2026. Verfasst von Nicole S Sarna und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Rice University, Houston, TX, United States. Hauptthemen laut MEDLINE: Lymphocyte Activation, T-Lymphocytes, Prostatic Neoplasms, Stress, Mechanical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Richard S. Reyolds Foundation, National Institutes of Health (NIH).
Abstract (Originalsprache)
Cancer patient-derived T cells often exhibit impaired activation and functional responsiveness due to chronic antigen exposure and therapy-induced immune dysregulation, limiting the efficacy of current immunotherapies. Mechanical forces, such as fluid shear stress (FSS), are emerging as critical regulators of immune cell activation, yet their role in modulating activation of patient-derived T cells remains largely unexplored. In this study, primary T cells isolated from patients with metastatic prostate cancer were exposed to FSS using a cone-and-plate viscometer during ex vivo activation in the presence and absence of bead-bound anti-CD3/CD28 monoclonal antibodies. FSS alone was sufficient to induce NF-κB phosphorylation and intracellular cytokine synthesis, demonstrating that mechanical stimulation can independently initiate T cell activation signaling. Moreover, FSS combined with anti-CD3/CD28 stimulation produced a synergistic increase in activation signaling, IL-2 and IFN-γ production, and CD25/CD69 expression. While trends were consistent across donors overall, inter-patient variability reflected differences in baseline T cell phenotype, with naïve-like cells displaying greater mechanosensitivity. These results indicate that cancer patient-derived T cells retain mechanotransduction capacity despite reduced antigen responsiveness. Incorporating FSS as a co-stimulatory signal during ex vivo expansion may be more effective at priming patient T cells for activation, enhancing effector function, and improving the efficacy of adoptive cell therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Rice University, Houston, TX, United States.
- Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, United States.
- Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
- Vanderbilt-Ingram Cancer Center, Nashville, TN, United States.
- Geriatric Research Educational and Clinical Center (GRECC), VA Tennessee Valley Healthcare System, Nashville, TN, United States.
ORCID-Profile: Nicole S Sarna, Michael R King
Förderung
- NCI NIH HHS
- Richard S. Reyolds Foundation
- National Institutes of Health (NIH)
- National Science Foundation Graduate Research Fellowship
- the Cancer Prevention and Research Institute of Texas
- The Welborn Fund
- SyBBURE Searle Undergraduate Research Program at Vanderbilt University
- James Rowen
Zitieren
APA
Sarna, N. S., Antunovic, M., Hurley, P. J., Schaffer, K. R., & King, M. R. (2026). Fluid shear stress as a co-stimulatory cue to enhance T cell priming and restore activation in cancer patient T cells. The Journal of Immunology, 215(8). https://doi.org/10.1093/jimmun/vkag166
Vancouver
Sarna NS, Antunovic M, Hurley PJ, Schaffer KR, King MR. Fluid shear stress as a co-stimulatory cue to enhance T cell priming and restore activation in cancer patient T cells. The Journal of Immunology. 2026;215(8). doi:10.1093/jimmun/vkag166
BibTeX
@article{Sarna2026,
author = {Sarna, Nicole S and Antunovic, Monika and Hurley, Paula J and Schaffer, Kerry R and King, Michael R},
title = {Fluid shear stress as a co-stimulatory cue to enhance T cell priming and restore activation in cancer patient T cells},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {8},
doi = {10.1093/jimmun/vkag166}
}
EUVIMED